Loading data
IBRXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 113.29 m USD | 14.75 m USD | 622 k USD | 240 k USD | 934 k USD |
| Cost of revenue | 753 k USD | 0 USD | 0 USD | 0 USD | — |
| Research and development expense | — | 190.14 m USD | 232.37 m USD | 248.15 m USD | 195.96 m USD |
| Selling, general and administrative expense | — | 168.78 m USD | 129.62 m USD | 102.71 m USD | 135.26 m USD |
| Operating profit | -256.03 m USD | -344.18 m USD | -362.25 m USD | -351.3 m USD | -330.28 m USD |
| Interest expense | 60.89 m USD | 114.59 m USD | 128.85 m USD | 63.52 m USD | 14.85 m USD |
| Profit before tax | -351.61 m USD | -413.65 m USD | -583.89 m USD | -417.29 m USD | -349.84 m USD |
| Income tax expense | -135 k USD | 0 USD | -40 k USD | 34 k USD | 9 k USD |
| Net income (reported basis) | -351.5 m USD | -413.6 m USD | -583.9 m USD | -417.3 m USD | -349.8 m USD |
| Net income attributable to common shareholders | -351.4 m USD | -413.56 m USD | -583.2 m USD | -416.57 m USD | — |
| Basic earnings per share | -0.38 USD/share | -0.59 USD/share | -1.15 USD/share | -1.04 USD/share | -0.89 USD/share |
| Diluted earnings per share | -0.38 USD/share | -0.62 USD/share | -1.15 USD/share | -1.04 USD/share | -0.89 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.